Ocular Therapeutix Statistics
Total Valuation
OCUL has a market cap or net worth of $1.88 billion. The enterprise value is $1.30 billion.
Important Dates
The last earnings date was Tuesday, May 5, 2026, before market open.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OCUL has 218.96 million shares outstanding. The number of shares has increased by 19.87% in one year.
| Current Share Class | 218.96M |
| Shares Outstanding | 218.96M |
| Shares Change (YoY) | +19.87% |
| Shares Change (QoQ) | +0.53% |
| Owned by Insiders (%) | 1.06% |
| Owned by Institutions (%) | 79.82% |
| Float | 184.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 36.35 |
| Forward PS | 31.74 |
| PB Ratio | 3.45 |
| P/TBV Ratio | 3.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 25.07 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.81, with a Debt / Equity ratio of 0.14.
| Current Ratio | 14.81 |
| Quick Ratio | 14.49 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -25.75 |
Financial Efficiency
Return on equity (ROE) is -68.55% and return on invested capital (ROIC) is -37.31%.
| Return on Equity (ROE) | -68.55% |
| Return on Assets (ROA) | -32.88% |
| Return on Invested Capital (ROIC) | -37.31% |
| Return on Capital Employed (ROCE) | -43.72% |
| Weighted Average Cost of Capital (WACC) | 9.46% |
| Revenue Per Employee | $160,117 |
| Profits Per Employee | -$893,840 |
| Employee Count | 325 |
| Asset Turnover | 0.09 |
| Inventory Turnover | 64.83 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +32.18% in the last 52 weeks. The beta is 0.93, so OCUL's price volatility has been similar to the market average.
| Beta (5Y) | 0.93 |
| 52-Week Price Change | +32.18% |
| 50-Day Moving Average | 8.99 |
| 200-Day Moving Average | 10.93 |
| Relative Strength Index (RSI) | 47.50 |
| Average Volume (20 Days) | 2,865,037 |
Short Selling Information
The latest short interest is 24.79 million, so 11.32% of the outstanding shares have been sold short.
| Short Interest | 24.79M |
| Short Previous Month | 24.53M |
| Short % of Shares Out | 11.32% |
| Short % of Float | 13.43% |
| Short Ratio (days to cover) | 7.49 |
Income Statement
In the last 12 months, OCUL had revenue of $52.04 million and -$290.50 million in losses. Loss per share was -$1.45.
| Revenue | 52.04M |
| Gross Profit | -175.06M |
| Operating Income | -299.44M |
| Pretax Income | -290.50M |
| Net Income | -290.50M |
| EBITDA | -294.82M |
| EBIT | -299.44M |
| Loss Per Share | -$1.45 |
Full Income StatementBalance Sheet
The company has $666.70 million in cash and $79.46 million in debt, with a net cash position of $587.24 million or $2.68 per share.
| Cash & Cash Equivalents | 666.70M |
| Total Debt | 79.46M |
| Net Cash | 587.24M |
| Net Cash Per Share | $2.68 |
| Equity (Book Value) | 581.57M |
| Book Value Per Share | 2.66 |
| Working Capital | 658.31M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$226.21 million and capital expenditures -$14.74 million, giving a free cash flow of -$240.94 million.
| Operating Cash Flow | -226.21M |
| Capital Expenditures | -14.74M |
| Depreciation & Amortization | 4.63M |
| Net Borrowing | n/a |
| Free Cash Flow | -240.94M |
| FCF Per Share | -$1.10 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -575.43% |
| Pretax Margin | -558.24% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OCUL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.87% |
| Shareholder Yield | -19.87% |
| Earnings Yield | -15.36% |
| FCF Yield | -12.74% |
Analyst Forecast
The average price target for OCUL is $26.00, which is 203.21% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $26.00 |
| Price Target Difference | 203.21% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 59.82% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OCUL has an Altman Z-Score of 5.3 and a Piotroski F-Score of 2.
| Altman Z-Score | 5.3 |
| Piotroski F-Score | 2 |
